WELCOME TO The HEALTHCARE REPORT
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Microbot Medical | December 28, 2021
Microbot Medical Inc.announced that it has entered into a strategic collaboration agreement with Stryker, a leading global medical technology company. The company will collaborate with Stryker’s Neurovascular division to integrate its neurovascular instruments with Microbot’s LIBERTY Robotic System to develop the world’s first dedicated robotic procedural kits for use in certain neurovascular procedures.
“We have already ensured that the L...
HIT Consultant | April 08, 2020
Jefferson Health, a leading academic health system in Pennsylvania and New Jersey has deployed LifeLink’s conversational chatbot solution to serve as the “Coronavirus digital front door” for Jefferson Health patients seeking information or treatment for COVID-19. Deployed in just days, AI-powered COVID-19 chatbot allows Jefferson clinical teams to remotely screen and prioritize cases without risk of exposure, provides massive scale in frontline response capabilities, and ...
HITInfrastructure | March 31, 2020
Allscripts annnounced it has created a specialized telehealth implementation plan for clients to implement virtual visits between providers and patients through its EHR-agnostic patient engagement platform. The platform, FollowMyHealth, will allow clients across the nation to sign up and telehealth visit capabilities in a quick timeframe to their patients. With our telehealth offering through the robust FollowMyHealth platform, Allscripts is helping clients adapt to the evolving healthcare envir...
Alkem Laboratories Ltd. | January 13, 2022
Alkem Laboratories Ltd. (Alkem) hereby announces to launch a unique patented technology for the treatment of Diabetic Foot Ulcer (DFU) in India. The solution would be based on disruptive 4D Bioprinting technology, which would be used to treat deep, non-healing chronic wounds and is expected to be launched in the Indian market in the latter half of 2022 post regulatory approval. This advanced technology for DFU management has a high scope of preventing amputations in diabetic patients. This te...
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE